AGENDA

 

DOWNLOAD AGENDA

 

Basel, 4 - 5 December 2019

Schedule

Create your personal agenda –check the favourite icon

Dec 309:00
Conference pass

Databiology - FAIR Data Hackathon

FAIR DATA HACKATHON
9:00Industry Keynote Presentation FAIR Principles overviewand relevanceAlexandra Grebe de Barron, Business Partner Real WorldEvidence, Bayer9:30Hackathon Begins12:00Lunch Break13:20Hackathon Continues 16:30 Hackathon Conclusion – Coding Stops16:45Teams present their pitches to the judges17:30Group Q&A18:00Drinks Reception and Networking18:30Winner Announcement / Prizes
Les Mara, Founder, Databiology Inc
Dec 314:00
Conference pass

By Invitation- Start Up Seminar & Pitches

Workshops - Day One Initiative
Start Up Investment PitchesBy Invitation Only Technology Park Basel Hochbergerstrasse 60C, 4057 Basel, Switzerland
Dec 314:00
Conference pass

Workshop - Quantum Computing in Pharmaceuticals

Workshop - Quantum Computing in Pharmaceuticals
Quantum ComputingUnderstanding the power and application of quantum computing in lifesciences + R&DWhat is it -Where are the advantages and what does it provide pharma? Learn from companies already embracing the technologies15:00Introduction to quantumcomputing in pharmaceuticalsMarielle Van Der Pol, Global Area Head, Research IT, Roche15:301 Qbit [invited]16:00Accenture [invited]16:30Roche Speaker17:00Panel 17:30Speaker TBC18:00Close
Marielle Van De Pol, Global Area Head, Research It, Roche
Dec 315:00
Conference pass

Design Thinking Workshop- Digital Transformation

Design Thinking Workshop- Innovation in Digital Transformation
Design Thinking Workshop (Basel Congress Center)In this session you will learn more about innovation management. You can learn from start-ups, large corporations, and early stage companies and their perspective on innovation management. This interactive workshop is a hands on experience on agile methods to support your innovation journey.Digital transformation is challenging for our industry and it requires a different mindset and approach to innovation. Learn from the different examples and experience yourself ways to boost your innovation fitness.Mediators: Alain Bindels, Head of InnovationFacilitation, RocheBasker Gummadi, Director Technology and Innovation, CelgeneJennifer Cham, User Experience Manager,EMBL-EBIIris Grossmann, CSO, CAMP4 TherapeuticsLearning how toconduct digital transformation and drive innovation into your company in astrategic manner
Moderator: Jennifer Cham, Lead User Experience Designer, EMBL- EBI
Moderator: Basker Gummadi, Director Technolgy And Innovation, Celgene
Dec 318:30
Conference pass

Health Data Driven Business Models Seminar

Workshops - Day One Initiative
Health Data Driven Business Models SeminarFree To Attend On Registration MarkthalleSteinentorberg 20, 4051 Basel, Switzerland

Create your personal agenda –check the favourite icon

Dec 408:45
Conference pass
Dec 409:40
Conference pass

Getting your data and applications ready for precision medicine

Keynotes
  • Learn about key capabilities of the underlying reference architecture for high performance data and AI (HPDA) to manage the ocean of data and optimize your AI and big data pipelines for analysis.
  • Understand how to improve data quality through advanced metadata management using content-based and policy-driven data classification & tagging.
  • Discover how to support hybrid multicloud workload orchestration with end-to-end automation of workflows, leveraging containers and cloud using a self-service 'App Hub'.
  • Hear about use cases from the world's fastest genomics pipeline to the largest variant database and explore how your organization can improve speed, scalability, collaboration and ease of use and gain significant cost efficiencies
Dec 410:00
Conference pass

New Frontiers in Data Science – the role of automation in accelerating scientific discovery

Keynotes
Dec 410:20
Conference pass

The future of data science at Janssen

Keynotes
Mathai Mammen, Global Head Of Research And Development, Johnson & Johnson
Dec 411:40
Conference pass

Roundtables

Keynotes
Accelerating operations and analytics with High Speed Data sharing across platforms and the world
Challenges in developing digital therapeutics
Joris Van Dam, Executive Director And Head Of Digital Therapeutics, Novartis
Data Architecture at AZ
Cassie Gregson, It Manager, AstraZeneca
Data collection & algorithmic training for biomedical tasks: utilisation and strategies
Data Lakes, Getting data ready for analytics, and Personalized Health Data
Christian Blumenroehr, Principal Scientist, F. Hoffmann-La Roche
Data Privacy and Democratisation
Dell EMC
Design thinking: Driving forwards innovation in pharmaceuticals
Basker Gummadi, Director Technolgy And Innovation, Celgene
EDHEN + BD4BO
EDHEN + BD4BO
EDHEN + BD4BO
Enabling R&D via Clinical Trial data sharing (Data 42)
Philippe Marc, Global Head Of Integrated Data Sciences, Novartis Institutes for Biomedical Research
Investment in AI and Healthcare in China
Vadim Shpak, Managing Director, Vickers Venture Partners
Is bad User Experience (UX) hindering drug discovery? What are the challenges and opportunities for UX in life science software and digital transformation?
Ronald Johnston, Director Of Product And E-Commerce, Merck Digital
Jennifer Cham, Lead User Experience Designer, EMBL- EBI
Lessons learned in running an AI-enabled operation for precision medicine – privacy, policy, and technical challenges and how we overcame them
Edmon Begoli, Chief Data Architect, Mvp Champion Principal Investigator, Oak Ridge National Laboratory (ORNL)
NTT Data
Oncology
Charlotte Ng, Group Leader, Head Of Research, University of Bern
Ontoforce
David Kreutzer, Associate Director, Digital Products, Merck KGaA
Partnerships across Pharma and Tech – Deals, IP and Timelines
Gregg Talbert, Global Head Digital And Personalized Health Care Partnering, Roche
Phage Display AI and Genomics – Using next generation AI and phage display to generate new immunological targets
Christian Bender, Data Scientist, Bayer
Rare Diseases
Sandra Almeida, Global Strategic Planning Lead, Rare Diseases And Digital, Takeda
Reproducibility in Bioinformatics and Big Data Analytics: Myth or Reality?
Raffaele Calogero, Professor, University of Torino
Roche
Roche
Roche
Roche
Takeda
Takeda
TEST 2
TEST 3
Title TBC
Salvatore La Rosa, CSO, Children's Tumor Foundation
Visualisation of good quality data and the pursuit of metrics to drive efficiencies in clinical trials
Stephan Cichos, Principal Data Manager, Bayer
Paolo Piraino, Head Of Genomics And Biomarker Statistics, Bayer
Chrysanthi Kefala Dori, Head Of Direct Subject Data Acquisition, Data Sciences And Analytics, Bayer US LLC
Western Digital
Dec 413:30
Conference pass

Chairs remarks

AI ML
Angeli Moeller, Head Of It Business Partnering Research, Bayer
Dec 413:30
Conference pass
Dec 413:30
Conference pass

Chairs remarks

DATA INTEGRATION
Alexander Krupp, Head Of Computational Life Science It Pharmaceuticals, Bayer
Dec 413:30
Conference pass

Chairs remarks

BIG DATA & ONCOLOGY
Sohini Chowdhury, Chief Executive Officer, Michael J. Fox Foundation
Dec 413:30
Conference pass

Chairs remarks

ANALYTICS PLATFORMS
Lena Granovsky, Director, Analytics And Big Data, Teva Pharmaceuticals
Dec 413:35
Conference pass

Developing a spin in AI and Drug Development Company

AI ML
Dec 413:35
Conference pass

Computational insight generation from population-level data in support of drug discovery programs

BIOINFORMATICS
Sàndor Szalma, Senior Director, Biomedical Informatics, Takeda
Dec 413:35
Conference pass

From data archiving to knowledge representation: Bioinformatics research infrastructure provision at EBI

DATA MANAGEMENT + STORAGE
Dec 413:35
Conference pass

Engaging the Global Health Ecosystem to invest in RWD/RWE to facilitate Translational Medicine and Drug Development Decision Making

RWE
Dec 413:35
Conference pass
Dec 413:35
Conference pass

Making Data Clinically Relevant

BIG DATA & ONCOLOGY
Dec 413:35
Conference pass

Data Privacy and Democratization an overview

CLINICAL TRIALS & PRECISION MEDICINE
Maria Chiara Atzori, Head Data Privacy Ch, NOVARTIS
Dec 413:35
Conference pass

Presentation

ANALYTICS PLATFORMS
Justin Lecher, Platform Lead Scientific Computing, AstraZeneca
Dec 413:55
Conference pass
Dec 413:55
Conference pass
Dec 413:55
Conference pass

CytoReason

BIG DATA & ONCOLOGY
Shai Shen-Orr, Chief Scientist, CytoReason
Dec 414:15
Conference pass
Dec 414:15
Conference pass

Sidra Bioinformatics Platform: towards advancing Genomic medicine in Qatar

BIOINFORMATICS
Dec 414:15
Conference pass

The sound of Data Science in Global IT Solution Centre

DATA MANAGEMENT + STORAGE
Mariusz Mulas, Head, Roche Global It Solution Centre, Roche
Dec 414:15
Conference pass

Vaccines and RWE

RWE
Lisa Weiss, Senior Director, Clinical Epidemiology And Vaccines, Pfizer
Dec 414:15
Conference pass

Opportunities from close integration of basic science, translational, and clinical data in an integrated health system

DATA INTEGRATION
Dec 414:15
Conference pass

What does Big Data mean in a world of Precision Oncology?

BIG DATA & ONCOLOGY
Adrian Cassidy, Vice President And Global Head Of Real World Evidence, NOVARTIS
Dec 414:15
Conference pass

Integrating a validated R environment into a company-wide analytics platform for Life Science R&D

ANALYTICS PLATFORMS
Dec 414:15
Conference pass

Wearable Validation

CLINICAL TRIALS & PRECISION MEDICINE
Donal Landers, Director - Digital Experimental Cancer Medicine Team, Cruk Manchester Institute/The Christie, Senior Director Physician, Early C, Cancer Research UK
Siobhan Southam, Digital Experimental Cancer Medicine Team - Strategic Engagement Leader, AstraZeneca
Dec 415:05
Conference pass

Chairs remarks

AI ML
Helmut Linde, Global Head Of Data Science And Analytics, Merck KGaA
Dec 415:05
Conference pass

Chairs remarks

BIOINFORMATICS
Sàndor Szalma, Senior Director, Biomedical Informatics, Takeda
Dec 415:05
Conference pass

Chairs remarks

DATA INTEGRATION
Waldemar Ockert, Director, Rwi Business Market Analytics, Astellas Pharma
Dec 415:05
Conference pass

Chairs remarks

BIG DATA & ONCOLOGY
Angeli Moeller, Head Of It Business Partnering Research, Bayer
Dec 415:05
Conference pass

Chairs remarks

CLINICAL TRIALS & PRECISION MEDICINE
Steffen Roellinger, Senior Vice President - Head Portfolio & Operations Of Clinical Operations, Pharma R&D, Bayer
Dec 415:10
Conference pass

AI in Pharma R&D within Pfizer

AI ML
Morten Sogaard, Vice President And Head, Genome Sciences And Technologies, Worldwide R&D, Pfizer
Dec 415:10
Conference pass

The dark matter of cancer genomics: Identifying unrecognizable structural variants in cancer genomes

BIOINFORMATICS
James Broach, Director Of The Penn State Institute For Personalized Medicine, Penn State College of Medicine
Dec 415:10
Conference pass

Essential aspects of data production for precision medicine

DATA MANAGEMENT + STORAGE
Edmon Begoli, Chief Data Architect, Mvp Champion Principal Investigator, Oak Ridge National Laboratory (ORNL)
Dec 415:10
Conference pass

Real World Evidence vs. AI

RWE
Dorothee Bartels, Chief Digital Science Officer, Boehringer Ingelheim Digital Lab BI X
Dec 415:10
Conference pass

FAIR data, data integration in ROCHE discovery

DATA INTEGRATION
Olivier Roche, Global Data Quality Coordinator, Biology Workflow Team Leader, Roche
Dec 415:10
Conference pass

Histogenomics case study: why and how to detect a tumor-driving molecular event in routine diagnosis data

BIG DATA & ONCOLOGY
Dec 415:10
Conference pass

Applications of RWE in clinical development

CLINICAL TRIALS & PRECISION MEDICINE
Eleni Lagkadinou, Vice President, Translational Medicine Oncology, Bayer HealthCare
Dec 415:10
Conference pass

Data Lakes, Getting data ready for analytics, and Personalized Health Data

ANALYTICS PLATFORMS
Dec 415:30
Conference pass
Dec 415:30
Conference pass
Dec 415:50
Conference pass

Opportunities and challenges of AI and Genomics investments across Pharma and Healthcare

AI ML
Vadim Shpak, Managing Director, Vickers Venture Partners
Alfred Scheidegger, Partner And Founder, Nextech Invest
Jenny Liu, Chief Information Office, Livzon Pharmaceuticals
Dec 415:50
Conference pass

Abuse or Mis-use of RNA-seq Data Normalization in Practical RNA-seq Data Analysis

BIOINFORMATICS
Shanrong Zhao, Director, Computational Biology And Bioinformatics,Worldwide Research And Development, Pfizer
Dec 415:50
Conference pass

Digital lab: An AstraZeneca perspective

DATA MANAGEMENT + STORAGE
Amrik Mahal, Head of IT – Early Science, AstraZeneca
Dec 415:50
Conference pass

Federated & Harmonised Real World Research in the EU 2020+: A Convergence of Intent,Collaboration & Technology?

RWE
Dec 415:50
Conference pass

Scalable Integration Methodology for Pharma Legacy Enterprises (SIMPLE)

DATA INTEGRATION
Arkadiusz Wojtowicz, Senior Enterprise Architect, Bayer
Dec 415:50
Conference pass

Oncology and leveraging health systems and precision medicine

BIG DATA & ONCOLOGY
Lauren Becnel, Global Real World Evidence Lead, Pfizer
Dec 415:50
Conference pass

Building Roches Global Data Catalogue

ANALYTICS PLATFORMS
Etzard Stolte, Global Head Of Knowledge Management Ptd, Roche
Dec 415:50
Conference pass

Towards more integrative approaches that may allow us to intervene earlier in-patient journeys

CLINICAL TRIALS & PRECISION MEDICINE
Dec 416:50
Conference pass
Dec 416:50
Conference pass

Chairs remarks

BIG DATA & ONCOLOGY
Angeli Moeller, Head Of It Business Partnering Research, Bayer
Dec 416:50
Conference pass

Chairs remarks

CLINICAL TRIALS & PRECISION MEDICINE
Joachim Luithle, Vice President And Head Of Clinical Development Operations, Bayer
Dec 416:55
Conference pass

Unconventional Machine Learning of Genome-wide Human Cancer Data

AI ML
  • We evaluated several unconventional machine learning (ML) strategies on actual human tumor data and showed for the first time the efficacy of multiple annealing-based ML algorithms for classification of high-dimensional, multi-omics human cancer data from the Cancer Genome Atlas.
  • To assess algorithm performance, we compared these classifiers to a variety of standard ML methods and results indicate the feasibility of using annealing-based ML to provide comparable classification of human cancer types and associated molecular subtypes and superior performance with smaller training datasets.
  • Our results provide compelling empirical evidence for the potential future application of unconventional computing architectures in the biomedical sciences.
Dec 416:55
Conference pass

Are CAR-T Therapies Living up to Their Hype? Leveraging Real World Data for a Comparative Effectiveness Study Are CAR-T therapies living up to their hype? Comparative effectiveness with RWE

RWE
Dec 417:15
Conference pass

Presentation

AI ML
Simon Lin, Chief Research Information Officer, Nationwide Children's Hospital
Dec 417:15
Conference pass

Patient journey in Oncology in 2025 - Molecular tumour boards in practice

BIOINFORMATICS
Dec 417:15
Conference pass

Giving Gut A Face - How to Enable Informed Technology Platform Portfolio Management

DATA MANAGEMENT + STORAGE
Christoph Huels, Internal Entrepreneur In Action, Merck KGaA
Dec 417:15
Conference pass

Multi-modal RWD: opportunities and challenges

RWE
Jacqueline Law, Vice President Global Head Phc Datascience, Genentech
Dec 417:15
Conference pass

Connecting the dots – knowledge graph in translational diabetes research

DATA INTEGRATION
Alexander Jarasch, Head Of Data And Knowledge Management, German center for diabetes research
Dec 417:15
Conference pass

PANEL: Big Data and Oncology Stratergy

BIG DATA & ONCOLOGY
Joseph Lehar, Vice President Data Science, Oncology, J&J, Janssen Pharmaceuticals
Anguraj Sadanandam, Team Leader, Institute of Cancer Research
Dec 417:15
Conference pass

Digital transformation across pharma

ANALYTICS PLATFORMS
Lena Granovsky, Director, Analytics And Big Data, Teva Pharmaceuticals
Dec 417:15
Conference pass

Whole Genome Sequencing and Personalized Medicine

CLINICAL TRIALS & PRECISION MEDICINE
David Smith, Professor, Mayo Clinic
Dec 417:35
Conference pass
Dec 417:35
Conference pass

databiology

DATA INTEGRATION
Dec 417:35
Conference pass

Patient centric digital trials and Boehringer

CLINICAL TRIALS & PRECISION MEDICINE
Sonia Houston Pichardo, Digital Trials Lead Europe, Boehringer Ingelheim
Dec 417:55
Conference pass

How AbbVie is implementing AI company wide- Organisational considerations

AI ML
Brian Martin, Head Of Ai In R&D Information Research, Senior Principal Data Scientist, AbbVie
Dec 417:55
Conference pass

Data visualization using JavaScript and R.

BIOINFORMATICS
Baohong Zhang, Head Of Genome Informatics, Biogen
Dec 417:55
Conference pass

Strategic insight from Merck: developments in architecture

DATA MANAGEMENT + STORAGE
Christopher Lamplugh, Avp, Head Of Global Data Management And Standards, Merck
Dec 417:55
Conference pass
Dec 417:55
Conference pass

Converting data and insights using a communal data ecosystem

DATA INTEGRATION
Vijay Bulusu, Head Of Data And Digital Innovation, Pfizer
Dec 417:55
Conference pass

Foundation Medicine

BIG DATA & ONCOLOGY
James Creeden, Global Medical Director, Foundation Medicine Inc
Dec 417:55
Conference pass

Precision Nutrition and Metabolic Diseases

CLINICAL TRIALS & PRECISION MEDICINE
Dec 417:55
Conference pass

Smart Investments in AI and Health – Driving value into hearlthcare using AI

ANALYTICS PLATFORMS

Create your personal agenda –check the favourite icon

Dec 508:25
Conference pass

Chair’s opening remarks

Keynotes
Nicola Blackwood, Parliamentary Under Secretary Of State, Department Of Health And Social Care, UK Government
Dec 508:50
Conference pass

Chief Data Officers Panel

Keynotes
Bryn Roberts, Senior Vice President And Global Head Of Operations Pharma Research And Early Development, Roche
Caroline Schmidt, Global Head Of Enterprise Digital Enterprise, Takeda Pharmaceuticals
Dirk Schapeler, Vice President Digital, Bayer Digital Transformation, Bayer
Dorothee Bartels, Chief Digital Science Officer, Boehringer Ingelheim Digital Lab BI X
Dec 509:40
Conference pass
Dec 513:30
Conference pass

Chair's remarks

AI ML
Steve Guise, Chief Information Office, Roche
Dec 513:30
Conference pass

Chair's remarks

BIOINFORMATICS
Peter Groenen, Head Of Translational Science, Idorsia
Dec 513:30
Conference pass

Chair's remarks

RWE
Michael Seewald, Worldwide Head Rwe And Digital, Novartis AG
Dec 513:30
Conference pass

Chair's remarks

DATA INTEGRATION
Andrea Splendiani, Director, Data Strategy, Novartis Pharma AG
Dec 513:30
Conference pass

Chair's remarks

DIGITAL HEALTH
Oliver Gassner, Head Digital Health Intelligence | Emea, Bayer
Dec 513:30
Conference pass

Chair's remarks

RARE DISEASES
Catherine Brownstein, Assistant Professor, Assistant Professor At Harvard Medical School, Director, Manton Center for Orphan Disease Research
Dec 513:35
Conference pass

Interoperability is Key - Overcoming Semantic Underspecification in Data and Information Architecture

DATA MANAGEMENT + STORAGE
Martin Romacker, Data And Information Architect, Roche
Dec 513:35
Conference pass

The Value of Trusted Partnerships between Pharma and Healthcare facilitated by Real-world data

RWE
Michael Seewald, Worldwide Head Rwe And Digital, Novartis AG
Dec 513:35
Conference pass

#WeAreNotWaiting for better diabetes care

DIGITAL HEALTH
Andrew Warrington, Project Leader - Digital Therapeutics Domain, NOVARTIS
Dec 513:35
Conference pass

Delivering whole-genome based rapid and precision medical care for babies admitted to NICUs around the world – data platforms, integrations, automations and AI

RARE DISEASES
Ray Veeraraghavan, Senior Director, Informatics & IM, Rady Children's Institute for Genomic Medicine
Dec 513:35
Conference pass

A new compound platform for enhanced access to chemical space for screening

ANALYTICS PLATFORMS
Roman Affentranger, Head Small Molecule Discovery Workflows, Roche
Dec 513:55
Conference pass

Accelerating discovery with Functional Genomics data

BIOINFORMATICS
Philippe Sanseau, Head Computational Biology And Stats, GSK
Dec 513:55
Conference pass

Using big data to improve patient outcomes - a nationally comprehensive, real-world cancer resource

RWE
Dec 513:55
Conference pass

mHealth from the trenches: precision medicine in the era of digital health

DIGITAL HEALTH
Dec 513:55
Conference pass

Rare Disease in a Big Data World

RARE DISEASES
Marshall Summar, Chairman, National Organization for Rare Disorders (NORD)
Dec 514:15
Conference pass

Using machine learning to select tool antibody candidates based on phage display pool sequencing data - an alternative to conventional screening?

AI ML
Christian Bender, Data Scientist, Bayer
Dec 514:15
Conference pass

Unlocking the potential of FAIR Data using AI

BIOINFORMATICS
Anna Bauer Mehren, Head Of Data Science, Roche
Dec 514:15
Conference pass

New methods of dealing with data

DATA MANAGEMENT + STORAGE
Jake Chen, Chief Bioinformatics Officer, University of Alabama at Birmingham
Dec 514:15
Conference pass

Commercial Culture – Driving digital and analytics to better patient outcomes

RWE
Bernard Hamelin, Global Head Of Evidence Generation, Sanofi
Dec 514:15
Conference pass

Bridging the Gap Between Biology and Technology

DATA INTEGRATION
Dec 514:15
Conference pass

How Voice-Enabled Technology Could Change the Healthcare Industry

DIGITAL HEALTH
David Herzig, Scientist Of Research Informatics, Roche Pharmaceuticals
Dec 515:10
Conference pass

Combining Blockchain, Machine learning and Process Automation to Optimize the Future of Clinical Development

AI ML
Basker Gummadi, Director Technolgy And Innovation, Celgene
Dec 515:10
Conference pass

Just Add Data Bio: Automating Machine Learning for Bioinformatics Predictive Analytics

BIOINFORMATICS
Dec 515:10
Conference pass
Dec 515:10
Conference pass

WORKSHOP: IMI2 BD4BO- (Big Data for Better Outcomes)

RWE
Dec 515:10
Conference pass

Designing and implementing an integrated data management platform for biologics research

DATA INTEGRATION
Ralph Haffner, 'Global Area Head - Research Informatics, Roche
Dec 515:10
Conference pass

Suitability of sensor-derived data for regulatory decision making

DIGITAL HEALTH
Paul Strijbos, Digital Innovation Leader, Digital Health Platforms, F. Hoffmann-La Roche
Dec 515:10
Conference pass

Interfacing with pharma and startups in the rare diseases space

RARE DISEASES
Catherine Brownstein, Assistant Professor, Assistant Professor At Harvard Medical School, Director, Manton Center for Orphan Disease Research
Dec 515:10
Conference pass

Presentation

ANALYTICS PLATFORMS
Gerald Hall, Principal Research Scientist, Eli Lilly and Company
Dec 515:30
Conference pass

Digital Transformation in research: A bottom-up approach, its promises and perils

DATA MANAGEMENT + STORAGE
Dec 515:50
Conference pass

Machine Learning and Causal Inference

AI ML
Hubert Misztela, Machine Learning Expert At Novartis, Lecturer At Dublin Business School, NOVARTIS
Dec 515:50
Conference pass

Demonstrating ROI on AI investment across a pharma company - concrete examples at Amgen

BIOINFORMATICS
Adrien Rousset, Innovation Lead - Patient Id And Predictive Analytics, Amgen
Dec 515:50
Conference pass

Go FAIR – Developing the FAIR ecosystem

DATA MANAGEMENT + STORAGE
Luiz Bonino, International Technology Coordinator, Go Fair
Dec 515:50
Conference pass

Data 42 – Developing a companywide search engine for R&D

DATA INTEGRATION
Philippe Marc, Global Head Of Integrated Data Sciences, Novartis Institutes for Biomedical Research
Dec 515:50
Conference pass

Data preprocessing and advanced analytics methods around wearable data in Heart Failure from a patch

DIGITAL HEALTH
Chrysanthi Kefala Dori, Head Of Direct Subject Data Acquisition, Data Sciences And Analytics, Bayer US LLC
Stephan Cichos, Principal Data Manager, Bayer
Paolo Piraino, Head Of Genomics And Biomarker Statistics, Bayer
Dec 515:50
Conference pass
Dec 515:50
Conference pass

Process mining in the real time and situations in hospital settings, prediction and decision makings

ANALYTICS PLATFORMS
Milan Bates, Cardiac Surgeon, Bristol Royal Infirmary
Dec 517:00
Conference pass

Chair's remarks

BIOINFORMATICS
Pedro Ballester, Group Leader, INSERM
Dec 517:05
Conference pass

Vision and Showcase of Machine Learning at Roche

AI ML
Dec 517:05
Conference pass

Machine Learning for Precision Oncology

BIOINFORMATICS
Pedro Ballester, Group Leader, INSERM
Dec 517:05
Conference pass

Portfolio Management in the Context of Industrial Data Science

DATA MANAGEMENT + STORAGE
Boris Adryan, Expert For Iot And Data Analytics, Chief Digital Office, Merck KGaA
Dec 517:05
Conference pass

The real-world evidence required by Pharma as digital innovation transitions from clinical trials to the adoption within a healthcare setting

RWE
Vipul Modi, Head Of Transformation For Innovation, Digital And Life Sciences, Oxford Academic Health Science Network
Dec 517:05
Conference pass

Overcoming challenges in the heterogeneity of patient data

DATA INTEGRATION
Mikhail Zaslavskiy, Chief Research Officer, OWKIN
Dec 517:05
Conference pass

IMI Digital Trials in Neurodegenerative Diseases

DIGITAL HEALTH
Emilio Merlo Pich, Vice President, Takeda Pharmaceuticals International GmbH (Vaccines)
Dec 517:05
Conference pass

[Topic pending]

RARE DISEASES
Sandra Almeida, Global Strategic Planning Lead, Rare Diseases And Digital, Takeda
Dec 517:05
Conference pass

Using Analytics within the World of Clinical

ANALYTICS PLATFORMS
Nareen Katta, Head Of Clinical Analytics Data And Statistical Sciences, AbbVie
Dec 517:25
Conference pass

BiowireTM II : Generating Human-relevant Data Sets from Tissue Engineering Platforms

AI ML
  • TARA generates proprietary human relevant data sets to enable predictive algorithm development.
  • The BiowireTM II tissue platform produces engineered heart tissue, with unprecedented functionality, that can predict human drug response.
  • These data sets can help bridge the translation gap between human as existing models.
Dec 517:25
Conference pass

Integrating AI into WGS at the forefront of clinical trials

BIOINFORMATICS
Sandra Smieszek, Head Of Genetics, Vanda Pharmaceuticals Inc
Dec 517:25
Conference pass

Patient-centered Analytic Learning Machine- PALM. A graph-based enterprise architecture for scalable and operational AI/ML in healthcare.

DATA INTEGRATION
Dec 517:25
Conference pass

euCanSHare H2020 project: building a big data multi-centre platform for enhancing data sharing and personalised medicine research in cardiology

RARE DISEASES
Dec 517:25
Conference pass

euCanSHare H2020 project: building a big data multi-centre platform for enhancing data sharing and personalised medicine research in cardiology

ANALYTICS PLATFORMS
Karim Lekadir, Coordinator, Universitat Pompeu Fabra
Dec 517:45
Conference pass

Achieving operational benefit and embracing novel opportunities in AI for early drug discovery

AI ML
Dec 517:45
Conference pass

Genetic studies at Novo Nordisk

BIOINFORMATICS
Martijn Van De Bunt, Head Of Department, Bioinformatics And Data Mining, Novo Nordisk
Dec 517:45
Conference pass

Applying AI in the Real World: Overcoming the Translational Barrier

RWE
Dec 517:45
Conference pass

Knowledge integration pipelines for systems pharmacology applications

DATA INTEGRATION
Dec 517:45
Conference pass

Defining the four main market challenges in the delivery of digital therapeutics

DIGITAL HEALTH
Joris Van Dam, Executive Director And Head Of Digital Therapeutics, Novartis
Dec 517:45
Conference pass

[Topic pending]

RARE DISEASES
Sandra Almeida, Global Strategic Planning Lead, Rare Diseases And Digital, Takeda
Dec 517:45
Conference pass

HPC and Big Data in the cloud

ANALYTICS PLATFORMS
Leonids Aleksandrovs, Analytics Integration Manager, UCB
last published: 19/Sep/19 08:25 GMT
 
 

Sign Up for Event Updates

Contact us

To sponsor or exhibit contact:
Alistair Wilmot
+44 (0)207 092 1174

alistair.wilmot@terrapinn.com


To speak:
Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com